Ability Pharmaceuticals, SA raised €7M in a financing round to advance the development of its clinical phase 2b Autophagy Inducer ABTL0812 in Metastatic Pancreatic Cancer.
Amount Raised
€7 Million
Round Type
Funding Round
BarcelonaBiotechnologyTherapeuticsBiopharmaInvestors
Description
Ability Pharmaceuticals, SA announced a €7 million investment from a European-Canadian syndicate of life sciences investors, including CTI Life Sciences Fund, Inveready, the EIC Fund, Fitalent, and CDTI Innvierte. The funding will allow the Company to fully finance its phase 2b clinical study of antitumor compound ABTL0812 in patients with pancreatic cancer.
Quick answer
Ability Pharmaceuticals SA raised €7 Million in a Funding Round round, dated March 11, 2024. Investors: CDTI Innvierte, Fitalent, EIC Fund, Inveready and CTI Life Sciences Fund. Ability Pharmaceuticals SA is based in Barcelona, Catalonia, Spain.
- How much did Ability Pharmaceuticals SA raise?
- Ability Pharmaceuticals SA raised €7 Million in a Funding Round round on March 11, 2024.
- Who invested in Ability Pharmaceuticals SA?
- CDTI Innvierte, Fitalent, EIC Fund, Inveready and CTI Life Sciences Fund are named as investors in this round.
- What does Ability Pharmaceuticals SA do?
- A Catalan biopharmaceutical company focused on the development of innovative oral autophagy-inducing anticancer compounds.
- Where is Ability Pharmaceuticals SA based and how big is it?
- Ability Pharmaceuticals SA is based in Barcelona, Catalonia, Spain.
- Who are the decision-makers at Ability Pharmaceuticals SA?
- Fundz holds 1 contact at Ability Pharmaceuticals SA. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as Ability Pharmaceuticals SA that raised within 45 days of this round, from Fundz verified event records.
- TORL BioTherapeutics raised $158M (Series B) on April 10, 2024.
- BioLineRx Ltd raised $20M (Pre-Seed) on April 10, 2024.
- Seaport Therapeutics raised $100M (Series A) on April 9, 2024.
- TORL BioTherapeutics raised $158M on April 4, 2024.
- AEON Biopharma raised $15M (Convertible Note) on March 21, 2024.
- BrickBio raised an undisclosed amount (Funding Round) on March 18, 2024.
Who to call at Ability Pharmaceuticals SA, and when
A new round usually means Ability Pharmaceuticals SA is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ability Pharmaceuticals SA raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ability Pharmaceuticals SA, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ability Pharmaceuticals SA. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ability Pharmaceuticals SA raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Ability Pharmaceuticals SA raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.